<p><b>A</b>. Analysis of caspase-3 activity in A549, H441 and H1299 lung cancer cells after SAHA, SL142 and SL325 treatment. Cells were treated with SAHA, SL142 or SL325 at a concentration of 2.5 µM for 36 hours. Triplicate experiments were performed; data represent the mean-fold increase ± S.E. Significant difference from cells treated with PBS and cells treated with HDAC inhibitors indicated was shown (*p<0.05, **<0.01). <b>B</b>. Flow cytometric analysis of apoptosis induced by SAHA, SL142 or SL325. Cells were infected with SAHA, SL142 or SL325 at the concentration of 2.5 µM for 72 hours and sub-G<sub>0</sub>/G<sub>1</sub> DNA content was measured by propidium iodide staining and flow cytometric analysis.</p
<p><b>A.</b> Representative flow cytometric analyses of apoptosis are shown. Four subpopulations and...
<p>A, B, Analysis of pH2AX and pChk2 expression and PARP cleavage in HCT116, HCT116+3, and HCT116+3+...
<p>(A), Pancreatic CSCs were treated with SAHA (3 and 5 µM) and 5-Aza-dC (2 and 4 µM) and cell viabi...
<p><b>A</b>. Analysis of caspase-3 activity induced by ATRA or <i>9-cis</i> RA (2.5 µM) and/or SAHA,...
<p>H358, H1650 and H1975 cells were incubated with a concentration range of su11274, and the cells w...
<p>14 days from starting treatment, tumors were harvested from mice of different ISA27 treatment gro...
Histone deacetylase (HDAC) inhibitors arrest cancer cell growth and cause apoptosis with low toxicit...
Histone deacetylase (HDAC) inhibitors arrest cancer cell growth and cause apoptosis with low toxicit...
<p>(<b>A</b>) Treatment of A549 and H1299 cells with GSPs reduces the level of caspase-9 while incre...
Histone deacetylase (HDAC) inhibitors arrest cancer cell growth and cause apoptosis with low toxicit...
<p><b>A</b>. Caspase 3/7 activity of HT1080 and HCT116 cells treated with increasing concentrations ...
Suberoylanilide hydroxamic acid (SAHA) is a well-known pan HDAC inhibitor, and its clinical applicat...
Suberoylanilide hydroxamic acid (SAHA) is a well-known pan HDAC inhibitor, and its clinical applicat...
<p>(A) Flow cytometric analysis of apoptosis after transfection with Flag-NS or the control vector. ...
<p>A, Analysis of pH2AX and pChk2 expression and PARP cleavage in <i>MSH3</i>–deficient HCT116+3+5 c...
<p><b>A.</b> Representative flow cytometric analyses of apoptosis are shown. Four subpopulations and...
<p>A, B, Analysis of pH2AX and pChk2 expression and PARP cleavage in HCT116, HCT116+3, and HCT116+3+...
<p>(A), Pancreatic CSCs were treated with SAHA (3 and 5 µM) and 5-Aza-dC (2 and 4 µM) and cell viabi...
<p><b>A</b>. Analysis of caspase-3 activity induced by ATRA or <i>9-cis</i> RA (2.5 µM) and/or SAHA,...
<p>H358, H1650 and H1975 cells were incubated with a concentration range of su11274, and the cells w...
<p>14 days from starting treatment, tumors were harvested from mice of different ISA27 treatment gro...
Histone deacetylase (HDAC) inhibitors arrest cancer cell growth and cause apoptosis with low toxicit...
Histone deacetylase (HDAC) inhibitors arrest cancer cell growth and cause apoptosis with low toxicit...
<p>(<b>A</b>) Treatment of A549 and H1299 cells with GSPs reduces the level of caspase-9 while incre...
Histone deacetylase (HDAC) inhibitors arrest cancer cell growth and cause apoptosis with low toxicit...
<p><b>A</b>. Caspase 3/7 activity of HT1080 and HCT116 cells treated with increasing concentrations ...
Suberoylanilide hydroxamic acid (SAHA) is a well-known pan HDAC inhibitor, and its clinical applicat...
Suberoylanilide hydroxamic acid (SAHA) is a well-known pan HDAC inhibitor, and its clinical applicat...
<p>(A) Flow cytometric analysis of apoptosis after transfection with Flag-NS or the control vector. ...
<p>A, Analysis of pH2AX and pChk2 expression and PARP cleavage in <i>MSH3</i>–deficient HCT116+3+5 c...
<p><b>A.</b> Representative flow cytometric analyses of apoptosis are shown. Four subpopulations and...
<p>A, B, Analysis of pH2AX and pChk2 expression and PARP cleavage in HCT116, HCT116+3, and HCT116+3+...
<p>(A), Pancreatic CSCs were treated with SAHA (3 and 5 µM) and 5-Aza-dC (2 and 4 µM) and cell viabi...